Zydus Lifesciences Limited has informed the Exchange regarding a press release dated May 17, 2024, titled "Zydus and MSN announces exclusive licensing and supply agreement for Cabozantinib Tablets (generic version of CABOMETYX��) for the US market".
Zydus Lifesciences Limited Press Release May 17 2024
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
In the deck
Earlier from Zydus Lifesciences
- Press Release May 11 2024
- Press Release May 09 2024
- Press Release May 04 2024
- Press Release Apr 26 2024
- Press Release Apr 23 2024
Later from Zydus Lifesciences
- Press Release May 22 2024
- Press Release May 24 2024
- Press Release Jun 14 2024
- Press Release Jun 28 2024
- Press Release Jul 04 2024
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences